Alvesco

Small airway function

Alvesco® improves small airway function.1-3 It significantly reduces small airway resistance and eosinophilic inflammation; this is in contrast to fluticasone propionate DPI2 (Figure 1). Read more
Section 2.2.1 Fig1

Figure 1: Alvesco® reduces the percentage of eosinophils in late-phase (small-airways-sampled) sputum2

Alvesco® also significantly increases Asthma Control Test™ (ACT) scores2 (Figure 2) and reduces small airway hyperresponsiveness.3 Read more

Section 2.2.1 Fig2

Figure 2: Alvesco® increases Asthma Control Test (ACT) scores2

See the section on Targeting small airways for more information on how Alvesco® targets this lung region.

References:

  1. Cohen J, Douma WR, ten Hacken NH, et al. Ciclesonide improves measures of small airway involvement in asthma. Eur Respir J 2008;31:1213-1220
  2. Hoshino M. Comparison of effectiveness in ciclesonide and fluticasone propionate on small airway function in mild asthma. Allergol Int 2010;59:59-66
  3. Cohen J, Postma DS, Douma WR, et al. Particle size matters: diagnostics and treatment of small airways involvement in asthma. Eur Respir J 2011;37:532-540
Loading ...